Published in PLoS One on April 18, 2012
Deciphering the biology of Mycobacterium tuberculosis from the complete genome sequence. Nature (1998) 60.62
Genes required for mycobacterial growth defined by high density mutagenesis. Mol Microbiol (2003) 16.82
New use of BCG for recombinant vaccines. Nature (1991) 14.40
A new evolutionary scenario for the Mycobacterium tuberculosis complex. Proc Natl Acad Sci U S A (2002) 13.50
Genetic requirements for mycobacterial survival during infection. Proc Natl Acad Sci U S A (2003) 9.15
Penicillinase synthesis controlled by infectious R factors in Enterobacteriaceae. Nature (1965) 8.77
Purification and characterization of a low-molecular-mass T-cell antigen secreted by Mycobacterium tuberculosis. Infect Immun (1995) 6.43
Deletion of RD1 from Mycobacterium tuberculosis mimics bacille Calmette-Guérin attenuation. J Infect Dis (2002) 5.15
Acute infection and macrophage subversion by Mycobacterium tuberculosis require a specialized secretion system. Proc Natl Acad Sci U S A (2003) 4.64
Type VII secretion--mycobacteria show the way. Nat Rev Microbiol (2007) 4.45
A recombinant Mycobacterium smegmatis induces potent bactericidal immunity against Mycobacterium tuberculosis. Nat Med (2011) 3.60
The ESAT-6 gene cluster of Mycobacterium tuberculosis and other high G+C Gram-positive bacteria. Genome Biol (2001) 3.58
Disclosure of the mycobacterial outer membrane: cryo-electron tomography and vitreous sections reveal the lipid bilayer structure. Proc Natl Acad Sci U S A (2008) 3.45
The ESAT-6/WXG100 superfamily -- and a new Gram-positive secretion system? Trends Microbiol (2002) 3.42
Evolution and expansion of the Mycobacterium tuberculosis PE and PPE multigene families and their association with the duplication of the ESAT-6 (esx) gene cluster regions. BMC Evol Biol (2006) 2.97
C-terminal signal sequence promotes virulence factor secretion in Mycobacterium tuberculosis. Science (2006) 2.72
PPE and PE_PGRS proteins of Mycobacterium marinum are transported via the type VII secretion system ESX-5. Mol Microbiol (2009) 2.68
SecA2 functions in the secretion of superoxide dismutase A and in the virulence of Mycobacterium tuberculosis. Mol Microbiol (2003) 2.62
Direct visualization of the outer membrane of mycobacteria and corynebacteria in their native state. J Bacteriol (2008) 2.60
rpsL+: a dominant selectable marker for gene replacement in mycobacteria. Mol Microbiol (1995) 2.49
Mycobacterium tuberculosis and the environment within the phagosome. Immunol Rev (2007) 2.42
ESAT-6 from Mycobacterium tuberculosis dissociates from its putative chaperone CFP-10 under acidic conditions and exhibits membrane-lysing activity. J Bacteriol (2007) 2.31
Comprehensive analysis of exported proteins from Mycobacterium tuberculosis H37Rv. Proteomics (2007) 2.24
Secretion and subcellular localizations of bacterial proteins: a semantic awareness issue. Trends Microbiol (2009) 2.14
Mycobacterial Esx-3 is required for mycobactin-mediated iron acquisition. Proc Natl Acad Sci U S A (2009) 2.10
Genetic analysis of the beta-lactamases of Mycobacterium tuberculosis and Mycobacterium smegmatis and susceptibility to beta-lactam antibiotics. Microbiology (2005) 2.04
A mycobacterium ESX-1-secreted virulence factor with unique requirements for export. PLoS Pathog (2007) 2.00
A specific secretion system mediates PPE41 transport in pathogenic mycobacteria. Mol Microbiol (2006) 1.97
Direct visualization by cryo-EM of the mycobacterial capsular layer: a labile structure containing ESX-1-secreted proteins. PLoS Pathog (2010) 1.76
Physical organization of lipids in the cell wall of Mycobacterium chelonae. Mol Microbiol (1993) 1.65
Characterization of a Mycobacterium tuberculosis ESX-3 conditional mutant: essentiality and rescue by iron and zinc. J Bacteriol (2009) 1.62
The specialized secretory apparatus ESX-1 is essential for DNA transfer in Mycobacterium smegmatis. Mol Microbiol (2008) 1.61
Bacterial artificial chromosome-based comparative genomic analysis identifies Mycobacterium microti as a natural ESAT-6 deletion mutant. Infect Immun (2002) 1.54
Diversity in Mycobacterium tuberculosis mannosylated cell wall determinants impacts adaptation to the host. Tuberculosis (Edinb) (2010) 1.50
A unique Mycobacterium ESX-1 protein co-secretes with CFP-10/ESAT-6 and is necessary for inhibiting phagosome maturation. Mol Microbiol (2007) 1.44
Molecular genetics of Mycobacterium tuberculosis pathogenesis. Annu Rev Microbiol (2003) 1.19
Characterization of novel Mycobacterium tuberculosis and Mycobacterium smegmatis mutants hypersusceptible to beta-lactam antibiotics. J Bacteriol (2005) 1.19
Mycobacterial secretion systems ESX-1 and ESX-5 play distinct roles in host cell death and inflammasome activation. J Immunol (2011) 1.17
Role of M. tuberculosis RD-1 region encoded secretory proteins in protective response and virulence. Tuberculosis (Edinb) (2008) 1.11
Protein export systems of Mycobacterium tuberculosis: novel targets for drug development? Future Microbiol (2010) 1.09
Identification of functional Tat signal sequences in Mycobacterium tuberculosis proteins. J Bacteriol (2008) 1.06
Solution structure of the Mycobacterium tuberculosis EsxG·EsxH complex: functional implications and comparisons with other M. tuberculosis Esx family complexes. J Biol Chem (2011) 1.04
New insights into the distribution of WXG100 protein secretion systems. Antonie Van Leeuwenhoek (2010) 1.00
Transcriptional analysis of ESAT-6 cluster 3 in Mycobacterium smegmatis. BMC Microbiol (2009) 0.97
Extracytoplasmic proteins of Mycobacterium tuberculosis - mature secreted proteins often start with aspartic acid and proline. Microbiology (2000) 0.97
The crystal structure of the Mycobacterium tuberculosis Rv3019c-Rv3020c ESX complex reveals a domain-swapped heterotetramer. Protein Sci (2010) 0.94
Beta-lactamase can function as a reporter of bacterial protein export during Mycobacterium tuberculosis infection of host cells. Microbiology (2007) 0.90
Computational analysis of the ESX-1 region of Mycobacterium tuberculosis: insights into the mechanism of type VII secretion system. PLoS One (2011) 0.86
The uracil DNA glycosylase UdgB of Mycobacterium smegmatis protects the organism from the mutagenic effects of cytosine and adenine deamination. J Bacteriol (2009) 0.82
Mycobacterium tuberculosis prevents inflammasome activation. Cell Host Microbe (2008) 3.25
Efficacy of pantoprazole 20 mg daily compared with esomeprazole 20 mg daily in the maintenance of healed gastroesophageal reflux disease: a randomized, double-blind comparative trial - the EMANCIPATE study. Eur J Gastroenterol Hepatol (2007) 2.07
A synthetic mammalian gene circuit reveals antituberculosis compounds. Proc Natl Acad Sci U S A (2008) 1.68
The majority of inducible DNA repair genes in Mycobacterium tuberculosis are induced independently of RecA. Mol Microbiol (2003) 1.63
Breaking down the wall: fractionation of mycobacteria. J Microbiol Methods (2006) 1.35
The functions of OmpATb, a pore-forming protein of Mycobacterium tuberculosis. Mol Microbiol (2002) 1.32
Deletion of dop in Mycobacterium smegmatis abolishes pupylation of protein substrates in vivo. Mol Microbiol (2009) 1.32
Engineering the rRNA decoding site of eukaryotic cytosolic ribosomes in bacteria. Nucleic Acids Res (2007) 1.30
Dop functions as a depupylase in the prokaryotic ubiquitin-like modification pathway. EMBO Rep (2010) 1.27
DNA damage induction of recA in Mycobacterium tuberculosis independently of RecA and LexA. Mol Microbiol (2002) 1.23
Lipoprotein synthesis in mycobacteria. Microbiology (2007) 1.22
Lack of mismatch correction facilitates genome evolution in mycobacteria. Mol Microbiol (2004) 1.21
Binding of neomycin-class aminoglycoside antibiotics to mutant ribosomes with alterations in the A site of 16S rRNA. Antimicrob Agents Chemother (2006) 1.15
Identification of apolipoprotein N-acyltransferase (Lnt) in mycobacteria. J Biol Chem (2009) 1.12
Antibodies protect against intracellular bacteria by Fc receptor-mediated lysosomal targeting. Proc Natl Acad Sci U S A (2010) 1.07
Tuberculosis vaccine strain Mycobacterium bovis BCG Russia is a natural recA mutant. BMC Microbiol (2008) 0.98
Dissecting the complete lipoprotein biogenesis pathway in Streptomyces scabies. Mol Microbiol (2011) 0.94
Characterization of the mycobacterial NER system reveals novel functions of the uvrD1 helicase. J Bacteriol (2008) 0.93
Identification of a Broadly Cross-Reactive Epitope in the Inner Shell of the Norovirus Capsid. PLoS One (2013) 0.92
LspA inactivation in Mycobacterium tuberculosis results in attenuation without affecting phagosome maturation arrest. Microbiology (2008) 0.92
Characterization of a Mycobacterium tuberculosis mutant deficient in pH-sensing adenylate cyclase Rv1264. Int J Med Microbiol (2006) 0.89
Relief from Zmp1-mediated arrest of phagosome maturation is associated with facilitated presentation and enhanced immunogenicity of mycobacterial antigens. Clin Vaccine Immunol (2011) 0.87
The biological and structural characterization of Mycobacterium tuberculosis UvrA provides novel insights into its mechanism of action. Nucleic Acids Res (2011) 0.87
Intra-oesophageal pH profiles and pharmacokinetics of pantoprazole and esomeprazole: a crossover study in patients with gastro-oesophageal reflux disease. Eur J Gastroenterol Hepatol (2003) 0.86
A mycobacterial smc null mutant is proficient in DNA repair and long-term survival. J Bacteriol (2007) 0.85
Functional characterization of the Mycobacterium tuberculosis zinc metallopeptidase Zmp1 and identification of potential substrates. Biol Chem (2012) 0.84
Crystal structure of Mycobacterium tuberculosis zinc-dependent metalloprotease-1 (Zmp1), a metalloprotease involved in pathogenicity. J Biol Chem (2011) 0.84
Cloning, expression and characterization of Mycobacterium tuberculosis lipoprotein LprF. Biochem Biophys Res Commun (2009) 0.83
Functional analyses of mycobacterial lipoprotein diacylglyceryl transferase and comparative secretome analysis of a mycobacterial lgt mutant. J Bacteriol (2012) 0.82
Involvement of CD252 (CD134L) and IL-2 in the expression of cytotoxic proteins in bacterial- or viral-activated human T cells. J Immunol (2009) 0.82
Phenylethyl butyrate enhances the potency of second-line drugs against clinical isolates of Mycobacterium tuberculosis. Antimicrob Agents Chemother (2011) 0.81
Lymph node targeting of BCG vaccines amplifies CD4 and CD8 T-cell responses and protection against Mycobacterium tuberculosis. Vaccine (2012) 0.80
Heartburn in patients with gastro-oesophageal reflux disease in Germany and Sweden: a study on patients' burden of disease. Pharmacoeconomics (2003) 0.78
Polyphosphates from Mycobacterium bovis--potent inhibitors of class III adenylate cyclases. FEBS J (2009) 0.78
Interaction of Rv1625c, a mycobacterial class IIIa adenylyl cyclase, with a mammalian congener. Mol Microbiol (2005) 0.77
Lipoproteins of slow-growing Mycobacteria carry three fatty acids and are N-acylated by apolipoprotein N-acyltransferase BCG_2070c. BMC Microbiol (2013) 0.77
Adverse Events Following International Normalized Ratio Reversal in Intracerebral Hemorrhage. Cerebrovasc Dis (2016) 0.76
Possible etiology of improvements in both quality of life and overlapping gastroesophageal reflux disease by proton pump inhibitor treatment in a prospective randomized controlled trial. BMC Gastroenterol (2013) 0.75
Efficacy and safety of ciclesonide in the treatment of 24,037 asthmatic patients in routine medical care. Respir Med (2010) 0.75
Substance P in serum and cerebrospinal fluid of depressed patients: no effect of antidepressant treatment. Psychiatry Res (2005) 0.75
Pilot study of on-demand therapy with pantoprazole 20mg for long-term treatment in patients with mild gastro-oesophageal reflux disease. Clin Drug Investig (2005) 0.75
Effectiveness and safety of ciclesonide in the treatment of patients with persistent allergic or non-allergic asthma in medical practice (Data from a non-interventional study conducted in Austria). Wien Klin Wochenschr (2014) 0.75